Analyst Ratings for Johnson & Johnson
Portfolio Pulse from Benzinga Insights
In the last quarter, Johnson & Johnson (NYSE:JNJ) received 18 analyst ratings, with 9 being somewhat bullish and 9 indifferent. The company's average 12-month price target is $189.89, which has increased by 5.76% over the past month.
September 08, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Johnson & Johnson received 18 analyst ratings in the last quarter, with a somewhat bullish outlook. The average 12-month price target is $189.89, up 5.76% over the past month.
The somewhat bullish ratings and the increase in the average 12-month price target indicate a positive outlook for Johnson & Johnson. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100